Mary Geissler

Mary Geissler possesses extensive experience in regulatory affairs within the pharmaceutical industry. Currently serving as Vice President of Global Regulatory Affairs at Dyne Therapeutics, Mary has held key roles such as Executive Director of Regulatory Affairs at Seres Therapeutics and Senior Director of Regulatory Affairs at Apellis Pharmaceuticals. Additionally, Mary has contributed to regulatory operations at Alkermes and served as Director of Global Regulatory Affairs at Shire, showcasing a strong background in navigating complex regulatory environments.